Eastman Chemical Rises On Unusually High Volume (EMN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Eastman Chemical Company (NYSE: EMN) is trading at unusually high volume Friday with 3.1 million shares changing hands. It is currently at two times its average daily volume and trading up $3.52 (+5.3%) at $69.87 as of 3:45 p.m. ET.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Eastman Chemical has a market cap of $10.38 billion and is part of the basic materials sector and chemicals industry. Shares are down 2.5% year to date as of the close of trading on Thursday.

Eastman Chemical Company, a specialty chemical company, engages in the manufacture and sale of chemicals, plastics, and fibers in the United States and internationally. The company has a P/E ratio of 22.9, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Eastman Chemical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Eastman Chemical Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids

Are Trump Stocks a Crowded Trade?

Avangrid Chart Shows Good Fundamentals Not Everything in Trading

Here's Why These 3 Stocks With Alluring Dividends Are Strong Buys

Bullish and Bearish Reversals for the Week